                         SEQUENCE LISTING

<110>  University of Georgia Research Foundation, Inc.
 
<120>  EGFR TARGETING COMPOUNDS AND METHODS OF USE THEREOF

<130>  10067-021WO1

<150>  62/011,908
<151>  2014-06-13

<160>  20    

<170>  PatentIn version 3.5

<210>  1
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  1

Tyr Asn Pro Thr Thr Tyr Gln Met 
1               5               


<210>  2
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  2

Leu Tyr Asn Pro Thr Thr Tyr Gln Met Asp 
1               5                   10  


<210>  3
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  Nle

<400>  3

Ala Tyr Asn Pro Thr Thr Tyr Gln Xaa Ala 
1               5                   10  


<210>  4
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  Nle

<400>  4

Cys Tyr Asn Pro Thr Thr Tyr Gln Xaa Cys 
1               5                   10  


<210>  5
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-Fmoc-4-azido-L-homoalanine

<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  N-Fmoc-L-propargylglycine

<400>  5

Xaa Tyr Asn Pro Thr Thr Tyr Gln Xaa Xaa 
1               5                   10  


<210>  6
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-Fmoc-L-propargylglycine

<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  N-Fmoc-4-azido-L-homoalanine

<400>  6

Xaa Tyr Asn Pro Thr Thr Tyr Gln Xaa Xaa 
1               5                   10  


<210>  7
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-Fmoc-5-azido-L-norvaline

<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  N-Fmoc-L-propargylglycine

<400>  7

Xaa Tyr Asn Pro Thr Thr Tyr Gln Xaa Xaa 
1               5                   10  


<210>  8
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-Fmoc-L-propargylglycine

<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  N-Fmoc-5-azido-L-norvaline

<400>  8

Xaa Tyr Asn Pro Thr Thr Tyr Gln Xaa Xaa 
1               5                   10  


<210>  9
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-Fmoc-6-azido-L-norleucine

<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  N-Fmoc-L-propargylglycine

<400>  9

Xaa Tyr Asn Pro Thr Thr Tyr Gln Xaa Xaa 
1               5                   10  


<210>  10
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-Fmoc-L-propargylglycine

<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  N-Fmoc-6-azido-L-norleucine

<400>  10

Xaa Tyr Asn Pro Thr Thr Tyr Gln Xaa Xaa 
1               5                   10  


<210>  11
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-Fmoc-L-propargylglycine

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  N-Fmoc-4-azido-L-homoalanine

<400>  11

Xaa Gln Tyr Xaa Asn Thr Thr Pro Tyr Xaa 
1               5                   10  


<210>  12
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  Nle

<400>  12

Ala Tyr Asn Pro Thr Thr Tyr Gln Xaa Ala 
1               5                   10  


<210>  13
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  Nle

<400>  13

Cys Tyr Asn Pro Thr Thr Tyr Gln Xaa Cys 
1               5                   10  


<210>  14
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Selenocystine

<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  Nle

<400>  14

Xaa Tyr Asn Pro Thr Thr Tyr Gln Xaa Cys 
1               5                   10  


<210>  15
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  Nle

<400>  15

Ala Tyr Asn Pro Thr Thr Tyr Gln Xaa Ala 
1               5                   10  


<210>  16
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  Nle

<400>  16

Cys Tyr Asn Pro Thr Thr Tyr Gln Xaa Cys 
1               5                   10  


<210>  17
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Selenocystine

<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  Nle

<400>  17

Xaa Tyr Asn Pro Thr Thr Tyr Gln Xaa Cys 
1               5                   10  


<210>  18
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  Nle

<400>  18

Ala Tyr Asn Pro Thr Thr Tyr Gln Xaa Ala 
1               5                   10  


<210>  19
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  Nle

<400>  19

Cys Tyr Asn Pro Thr Thr Tyr Gln Xaa Cys 
1               5                   10  


<210>  20
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Selenocystine

<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  Nle

<400>  20

Xaa Tyr Asn Pro Thr Thr Tyr Gln Xaa Cys 
1               5                   10  


